ETR:MED Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	25.49	24.84	-10.78	9.44	1.46
Depreciation & Amortization	60.22	50.28	52.28	71.4	73.64
Loss (Gain) From Sale of Assets	-0.11	-0.23	-0.05	-0.24	-0.09
Asset Writedown & Restructuring Costs	-	-	33.73	-	0.02
Other Operating Activities	27.76	26.68	28.13	3.53	5.21
Change in Other Net Operating Assets	-10.92	-21.01	-25.31	-49.5	1.73
Operating Cash Flow	102.44	80.57	78	34.64	81.97
Operating Cash Flow Growth	27.15%	3.29%	125.18%	-57.74%	-30.94%
Capital Expenditures	-48.43	-38.04	-34.42	-24.37	-15.23
Sale of Property, Plant & Equipment	0.31	0.97	0.47	0.67	0.29
Divestitures	-	9.5	8.65	-	-
Sale (Purchase) of Intangibles	-3	-6.65	-3.16	-1.65	-1.78
Investment in Securities	-0.1	-0.01	-0.04	-0.04	-0.04
Other Investing Activities	14.08	19.1	18.99	19.14	9.66
Investing Cash Flow	-37.14	-15.13	-9.51	-6.24	-7.09
Long-Term Debt Repaid	-77.11	-50.38	-23.65	-46.1	-46.97
Net Debt Issued (Repaid)	-77.11	-50.38	-23.65	-46.1	-46.97
Common Dividends Paid	-1.9	-	-	-	-
Other Financing Activities	-20.97	-22.78	-21.83	-10.07	-8.3
Financing Cash Flow	-99.97	-73.16	-45.48	-56.17	-55.26
Net Cash Flow	-34.67	-7.73	23.01	-27.77	19.62
Free Cash Flow	54.01	42.52	43.58	10.27	66.74
Free Cash Flow Growth	27.02%	-2.43%	324.41%	-84.61%	-30.80%
Free Cash Flow Margin	6.71%	5.58%	5.72%	1.43%	9.76%
Free Cash Flow Per Share	1.14	0.90	0.92	0.22	1.41
Cash Interest Paid	-	22.78	21.83	10.07	8.3
Cash Income Tax Paid	-	3.02	-2.83	3.24	2.37
Levered Free Cash Flow	12.11	34.8	15.87	7.02	50.92
Unlevered Free Cash Flow	25.9	48.8	29.81	13.33	56.58
Change in Working Capital	-10.92	-21.01	-25.31	-49.5	1.73

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.